RVMD
Revolution Medicines, Inc.
Stock
$205.26+0.78 (+0.38%)Close Sep 30, 2026
| Capital expenditures (TTM) | YoY | 5-year CAGR |
|---|---|---|
| $9.1M | −41.1% | 40.4% |
| Capital expenditures (TTM) | $9.1M |
|---|---|
| YoY | −41.1% |
| 5-year CAGR | 40.4% |
Capital expenditures
| Period | Capex | YoY |
|---|---|---|
| 2025 | $16M | +55.1% |
| 2024 | $10M | +33.4% |
| 2023 | $7.7M | −28.5% |
| 2022 | $11M | +65.7% |
| 2021 | $6.5M | +122.6% |
| 2020 | $2.9M | +13.3% |
| 2019 | $2.6M | +72.7% |
| 2018 | $1.5M | — |